Publicaciones en las que colabora con Omar Al-Massadi Iglesias (45)

2024

  1. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

2023

  1. Editorial: Central and peripheral mechanism interfering in metabolic syndrome

    Frontiers in Endocrinology

2022

  1. Crosstalk between Melanin Concentrating Hormone and Endocrine Factors: Implications for Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  2. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  3. Liver Brain Interactions: Focus on FGF21 a Systematic Review

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  4. Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

    Reviews in Endocrine and Metabolic Disorders, Vol. 23, Núm. 5, pp. 919-930

  5. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis

    Nature Reviews Endocrinology, Vol. 17, Núm. 12, pp. 745-755

  2. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner

    Redox Biology, Vol. 41

2020

  1. Ghrelin and liver disease

    Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 1, pp. 45-56

  2. Oral Pharmacological Activation of Hypothalamic Guanylate Cyclase 2C Receptor Stimulates Brown Fat Thermogenesis to Reduce Body Weight

    Neuroendocrinology, Vol. 110, Núm. 11-12, pp. 1042-1053

  3. Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Exciting advances in GPCR-based drugs discovery for treating metabolic disease and future perspectives

    Expert Opinion on Drug Discovery, Vol. 14, Núm. 5, pp. 421-431

  2. Ghrelin and food reward

    Neuropharmacology, Vol. 148, pp. 131-138

  3. Glucagon control on food intake and energy balance

    International Journal of Molecular Sciences, Vol. 20, Núm. 16

  4. MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance

    Diabetes, Vol. 68, Núm. 12, pp. 2210-2222

  5. Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions

    Journal of Endocrinology, Vol. 240, Núm. 3, pp. 483-496

2018

  1. Ghrelin and LEAP-2: Rivals in Energy Metabolism

    Trends in Pharmacological Sciences, Vol. 39, Núm. 8, pp. 685-694

  2. P53 and energy balance: Meeting hypothalamic AgRP neurons

    Cell Stress, Vol. 2, Núm. 11, pp. 329-331

  3. p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1

    Nature Communications, Vol. 9, Núm. 1